Article
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research - 1 Dec 2011
Woods Beth, Veenstra David, Hawkins Neil
Abstract excerpt
OBJECTIVES: To demonstrate how value of information (VOI) analysis can be used to establish research priorities regarding the use of pharmacogenetic tests using CYP2D6 testing to select adjuvant hormonal therapy in early stage breast cancer as a case study. METHODS: The following four treatment pathways are compared in a Markov model: tamoxifen treatment; CYP2D6 test and treat homozygous and heterozygous wild...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
